Literature DB >> 33603958

Novel Spiropiperidine Allosteric Modulators of Nicotinic Acetylcholine Receptors for Treating Central Nervous System Disorders.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 33603958      PMCID： PMC7883373          DOI： 10.1021/acsmedchemlett.0c00670

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Snake three-finger α-neurotoxins and nicotinic acetylcholine receptors: molecules, mechanisms and medicine.

Authors:  Selvanayagam Nirthanan
Journal:  Biochem Pharmacol       Date:  2020-07-23       Impact factor: 5.858

Review 2.  The role of nicotinic acetylcholine receptors in alcohol-related behaviors.

Authors:  C N Miller; H M Kamens
Journal:  Brain Res Bull       Date:  2020-07-22       Impact factor: 4.077

Review 3.  Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies.

Authors:  Alan S Lewis; Marina R Picciotto
Journal:  Neuropharmacology       Date:  2019-12-26       Impact factor: 5.250

Review 4.  Nicotinic receptor pharmacology in silico: Insights and challenges.

Authors:  Alican Gulsevin
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

Review 5.  α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future.

Authors:  Alvin V Terry; Patrick M Callahan
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

Review 6.  Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling.

Authors:  Roger L Papke; Jon M Lindstrom
Journal:  Neuropharmacology       Date:  2020-02-28       Impact factor: 5.250
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.